In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Xenova nets £19.4mm in private UK and US placements

Executive Summary

Oncology and immunology drug company Xenova Group PLC raised net proceeds of £19.4mm ($32.9mm) through the sale of 18.7mm units priced at £1.13 apiece (a 14% discount to the market average). Each unit consisted of 10 shares and 3 warrants, amounting to an aggregate of about 187mm shares and 56mm warrants.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies